Abstract Background: Nuclear unrest is a term applied to Wilms' tumors (WT) that show nuclear abnormalities close to anaplasia but without abnormal mitoses. p53 is claimed to be associated with anaplasia and poor prognosis. This study was undertaken to evaluate the clinical significance of nuclear unrest and p53 immunostaining in Wilms' tumor. Material and methods: This is a retrospective study of 63 patients who presented at NCI with Wilms' tumors, and underwent preoperative chemotherapy followed by nephrectomy. Histopathologic assessment and p53 immunohistochemistry were done. Results: WT with nuclear unrest grade III closely resembled anaplastic tumors and both of them (group 1) constituted 19% of cases. Group 1 constituted 29% of cases showing blastema dominant morphology compared to 9.4% of cases without blastema dominant morphology with significant statistical difference (p = 0.047). Almost 83% of cases that achieved 1st complete remission were stages I, II and III, while 17% were stages IV and V with significant statistical difference (p < 0.001). Stage affected the 3-year relapse-free-survival (RFS) significantly (p = 0.014) as it was more in stages I, II and III than in stages IV and V (75.4% versus 50%). Blastema dominant morphology and high risk state significantly lowered the 3-year overall survival (OS) into 54.8% in comparison to 80.9% for cases with non-blastema dominant morphology (p = 0.042). Regarding p53 immunohistochemistry, group 1 tumors showed positive p53 more than group 2 with significant * Corresponding author. Address: Department of Pathology, Surgical Pathology Unit, National Cancer Institute, Cairo University, Egypt. Tel.: +20 224044321, +20 118864044. E-mail address: almadina.salama@gmail.com (A. Salama).
Introduction
Renal tumors are the fifth most common tumor in the first 15 years of life comprising 7%, coming after leukemia, brain cancer, soft tissue sarcomas and non-Hodgkin lymphoma (NHL). Wilms' tumor is by far the most common pediatric renal tumor ($85% of cases) [1] . Histologic classification is the most potent prognostic indicator for patients with Wilms' tumor as stated by the first National Wilms' Tumor Study Group (NWTSG-1) which implies treating Wilms' tumors by surgery first followed by, if necessary, postoperative chemotherapy and/or radiotherapy. This study classified Wilms' tumor into favorable histology and anaplastic Wilms' tumor, the latter is associated with adverse outcome. Anaplasia is defined by the presence of large nuclear size, hyperchromasia and irregular mitotic figures [2] .
On the other hand, preoperative chemotherapy has been an essential part of the International Society of Pediatric Oncology (SIOP) treatment strategy since its first trials, and so, its histologic classification differs as it reflects chemotherapy-induced changes. The revised SIOP histologic classification divides Wilms' tumor into three risk groups: (a) low risk (completely necrotic nephroblastoma and cystically partially differentiated nephroblastoma); (b) intermediate risk (regressive, epithelial, stromal, mixed, or focal anaplastic nephroblastoma); and (3) high risk (blastemal and diffuse anaplastic nephroblastoma) [3, 4] .
Some Wilms' tumors within the favorable histology category show disturbing nuclear enlargement, cytologic atypia, and histologic disarray that do not quite attain the degree of severity required for a designation of anaplasia, what is known as nuclear unrest [5] . Because the clinical significance of nuclear unrest has not been studied systematically, the appropriate treatment for patients with such tumors is unclear, making patients having tumors with nuclear unrest to be currently treated by regimens used for patients with tumors showing favorable histology, regardless of the cytologic similarities between tumors with nuclear unrest and anaplastic tumors which provide a source of anxiety for pathologists as well as for clinicians [6] .
In addition, although several studies have shown that detection of p53 by immunostaining is strongly associated with anaplasia in Wilms' tumor, yet the association with nuclear unrest has not been studied enough [7] . It is well known that a functional p53 protein has been linked to cell cycle checkpoint control, and the presence of p53 mutations may contribute to the increased DNA content and the irregular mitotic figures observed in anaplastic Wilms' tumor [8] . Moreover, the importance of p53 in directing cells with DNA damage into an apoptotic pathway may provide a molecular basis for the insensitivity of anaplastic tumors to therapeutic intervention [9] .
We aim at evaluation of p53 expression and nuclear unrest in Wilms' tumor through a retrospective study to elucidate their clinical significance.
Patients and methods
This retrospective study was initially conducted on all patients presenting to the Pediatric Oncology Clinic, National Cancer Institute (NCI), Cairo University from January 1, 2001 to December 31, 2008 and diagnosed as having Wilms' tumor. Of 132 patients, 42 patients were excluded because their paraffin blocks were not available (nephrectomies were done outside our institute). Ten cases were excluded because of inadequate sampling and unavailable clinical data. Seventeen cases were not included because of extensive necrosis which hindered immunohistochemical study. Our study was limited to 63 patients only to justify the adequacy of tumor sampling by examination of at least four representative slides for each case.
According to the SIOP WT protocol, children were treated with preoperative chemotherapy then followed by surgery and further chemotherapy with or without radiotherapy, if necessary. The tumors were histologically classified into three risk groups: (a) low risk (cystic partially differentiated nephroblastoma), (b) intermediate risk (regressive, epithelial, stromal, or mixed), and (c) high risk (blastemal or diffuse anaplasia) [4] . Complete remission (CR) was achieved by complete disappearance of the disease (primary tumor and its metastasis if present), whether by surgery alone or by surgery followed by chemotherapy and/or radiotherapy. It could be either first after tumor diagnosis or second after occurrence of relapse.
A diagnosis of anaplasia was made according to NWTS Group criteria: (1) an increase in greatest nuclear dimension at least three times that of adjacent nuclei of the same cell type; (2) hyperchromasia of the enlarged nuclei; and (3) the presence of abnormal multipolar mitotic figures. The criteria used to identify tumors with nuclear unrest and grade them were: grade 1 unrest reflects minimal disorder with nuclear diameter approximating that of RBC, while grade 3 connotes striking cytologic atypia and histologic disarray without multipolar mitotic figures and just short of anaplasia. Grade 2 is intermediate [10] . Tumor stage was determined from the clinical files using SIOP WT 2001 staging criteria [11] .
Four hematoxylin and eosin slides of each case were prepared for proper evaluation of tumor type, chemotherapy induced changes and assessment of anaplasia.
Immunohistochemical analysis of p53 was performed on 4 lm thick, formalin fixed, paraffin embedded tissue sections which were treated with heat in a water bath (95-99°C) for 20 min. Target retrieval involves immersion of tissue sections in a pre-heated citrate buffer at pH 9 for 30 min. The mouse monoclonal antihuman p53 antibody (DO-7 ready to use; Dako, Denmark) was applied and incubated overnight. Slides were developed with an avidin-biotin-peroxidase complex technique [12] . Positive controls were done using sections from known positive p53 breast carcinoma cases.
For assessment of p53 immunostaining, tumor cells with clearly brown reaction in the nuclei were counted by monitoring at least 1000 tumor cells from more than five high power fields where positive cells were present at relatively uniform density, and the percentage was then calculated. The numbers of immunopositive cells were counted and the case was categorized as negative when none or only a few (<5%) cells on the whole slide showed a weak staining [13] .
Data were analyzed using the SPSS statistical package. Numerical data were expressed as median, maximum and minimum. Qualitative data were expressed as frequency and percentage. The chi-square test and Fisher's exact test were used to examine the relation between qualitative variables. Survival analysis was carried out using the Kaplan-Meier method and presented as cumulative survival rates. Comparison between two survival curves was done using the log-rank test. Probability (p-value) equal or less than 0.05 was considered significant, and if less than 0.001, highly significant. Relapse-free survival (RFS) was calculated only for patients who achieved complete remission (CR) [14] . To study the independent effect of each significant factor on RFS and OS, significant factors were entered into a stepwise Cox proportional hazards model. Table 1 summarizes the clinical characteristics of the 63 patients who were included in the study as well as associations between clinical characteristics and histopathologic features. Patient ages at time of diagnosis ranged from 0.3 to10 years with a median age 3 years. Males and females were almost equally affected (49.2% and 50.8%, respectively). Tumors were classified histologically as favorable histology (34.9% of cases), unfavorable histology (6.4%), and tumors with nuclear unrest (58.7%) (Fig. 1) . The latter showed grade I unrest in 37.84%, grade II unrest in 40.54%, and grade III unrest in 21.62%.
Results

Patient characteristics
Histopathologically, the only difference between tumors with anaplasia and tumors with grade III nuclear unrest is detection of multipolar mitosis. The latter necessitates meticulous microscopic examination of multiple sections taken from each centimeter of maximal tumor diameter. This was not possible in this study being retrospective. Moreover, due to the small number of tumors with anaplasia, combination of those cases with tumors showing grade III unrest was done and named as Group 1. The rest of cases, tumors with favorable histology and tumors with nuclear unrest grade I and II, were also combined together and named as Group 2. Group 1 constituted 19% of all cases. Group 1 constituted 29% of cases that showed blastema dominant morphology compared to 9.4% of cases without blastema dominant morphology with significant statistical difference (p = 0.047). Consequently, group 1 constituted 29% of cases carrying a high risk state compared to 9.4% of cases with low and intermediate risk with Morphologic subtypes included blastema dominant morphology (49.2%), mixed (27%), epithelial dominant (7.9%), stroma dominant (7.9%), regressive (6.3%), and cystically partially differentiated nephroblastoma (CPDN) (1.6%). Consequently, high risk patients constituted 49.2%, intermediate risk patients were 49.2%, and low risk patients were 1.6% of our patient population. Table 2 illustrates tumor stages which included stage I (22.2%), II (12.7%), III (41.3%), IV (14.3%), and V (9.5%). All cases of stage V had having lung metastases. For statistical reasons, combination of stages I, II, and III was done (representing tumors that were localized abdominally), and stages IV and V were also combined together (representing tumors with distant spread). Advanced stage (IV and V) constituted 31% of children older than 3 years in contrast to 17.6% of children younger than or aged 3 years with significant statistical difference (p = 0.047). About 37.5% of female children presented with advanced stage in comparison to 9.7% of male children with significant statistical difference (p = 0.01). No significant association was detected between stage and either tumor histology (p = 0.767), morphologic subtype (p = 0.338) or risk state (p = 0.338).
p53 Immunohistochemistry analysis p53 was positive in 38 cases (60.3%) and staining was seen in blastema cells and tubules. The stroma was invariably negative. The majority of tumors of group 2 showed few scattered tumor cells with weak nuclear staining, while diffuse strong staining was achieved in tumors of group 1 (Fig. 2) . Histology was significantly associated with p53 immunoreaction as the majority of group 1 (91.7%) showed positive p53 in contrast Table 3 ).
Outcome analysis
Among 63 patients, the median follow-up was 34.9 months (range, 2.2-111.5 months). Complete remission was achieved in 58 patients (92.1% of cases). Almost 83% of cases that achieved 1st complete remission were stages I, II and III, while 17.2% were stages IV and V with a highly significant statistical difference (P < 0.001).
The three-year relapse-free-survival (RFS) was 65%. Relapse sites included local recurrence in 6 patients, distant metastases (lung, liver, brain and bone) in 6 patients, and both local and distant recurrence in 9 patients. Lung metastasis occurred in 13 cases while abdominal recurrence occurred in 15 cases. The effect of age, gender, stage, histology, morphologic subtype, risk and p53 on 3-year RFS is shown in Table  4 . Stage affected 3-year RFS significantly (Fig. 3) . The 3-year The three-year overall survival (OS) was 68.5% (Table 5 ). Advanced stage (IV and V) significantly lowered 3-year OS into 40% in contrast to 77.8% for stages I, II and III (Fig. 4) . Blastema dominant morphology and high risk state were significantly associated with worse 3-year OS (Fig. 5) . No significant association was obtained between 3-year OS and either age (p = 0.219), histology or p53 overexpression (p = 0.783).
Multivariate analysis was done using the Cox proportional hazards model for the study of the effect of prognostic factors on relapse free survival and overall survival as shown in Table 6 . Tumor stage was the only independent significant prognostic factor. The chance of relapse among stages IV and V was 3 times more than others (p = 0.016, 95% CI for HR 1.23-7.58). The probability of death among stages IV and V was 3.8 times more than others (p = 0.004, 95% CI for HR 1.55-9.45).
Discussion
Wilms' tumor is the most common primary renal malignancy of childhood. The median age at diagnosis in our study was 36 months, which is comparable to a Turkish study by Yildiz et al. [15] . In our study, stage I constituted 22.2% of cases, stage II (12.7% of cases), stage III (41.3% of cases), stage IV (14.3% of cases) and stage V (9.5%). Less advanced stages were reported by other Western and Asian studies. In the 2nd UKCCS [16] , NWTS [17] and SIOP [18] , stage I accounted for 34%, 47% and 61%, respectively. In the Taiwanese [19] , Turkish [15] and 3rd NWTS [20] , stage IV accounted for only 6.8%, 9% and 10%, respectively. We also noticed that female patients presented with advanced stage (IV and V) more than males (80% versus 20%, respectively). This may reflect lack of awareness among the mothers of our patients and reluctant attitude toward female children more than males and diminution of medical services in the rural areas of our country. Wilms' tumor with nuclear unrest has morphologic features that are intermediate between tumors with favorable histology and anaplastic tumors. The significance of this morphologic change is unclear, and it is uncertain whether patients who have these tumors necessitate more aggressive treatment than the treatment provided for patients who have tumors with favorable histology. We noticed that Wilms' tumor with nuclear unrest grade III closely resembled tumors with anaplastic histology (constituted group 1) than tumors with favorable histology or tumors with nuclear unrest grade I and II (constituted group 2) regarding blastema dominant morphology and high risk state. Group 1 constituted 29% of cases showing blastema dominant morphology and high risk state compared to 9.4% of cases without blastema dominant morphology and with low and intermediate risk with significant statistical difference (p = 0.047). This enforces our suggestion that tumors with anaplasia and tumors with nuclear unrest grade III are close to each other biologically sharing blastema dominant morphology which is known to carry a high risk state. However, there was no significant difference between tumors of group 1 and tumors of group 2 regarding age, gender, stage, and achievement of 1st CR. This was in agreement to what was reported by Hill et al. [6] Our study demonstrated that blastema dominant morphology was the most prevalent morphologic subtype (49.2%) which was higher than what was documented by Weirich et al. [21] who reported that in the immediately operated WTs the most common subtype was mixed (45.1%), followed by blastemal (39.4%) and epithelial predominant (15.5%), whereas in tumors that received preoperative chemotherapy, the most common type was regressive (37.6%), followed by mixed (29.4%), stromal (14%), blastemal (9.3%) and epithelial predominant (3.1%); 6.6% of tumors were completely necrotic.
In our study, positive p53 immunostaining was significantly more prevalent in group 1 than in group 2 (91.7% versus 52.9%, respectively). This highlights the resemblance of nuclear unrest grade III to anaplasia. Moreover, blastema dominant morphology was significantly associated with prevalent p53 overexpression. p53 Overexpression usually reflects p53 gene mutation resulting in increased DNA content, accumulation of genetic damage with failure in directing cells with DNA damage into an apoptotic pathway culminating in the insensitivity to therapeutic intervention. This could explain why blastema dominant morphology denotes high risk state as documented by the revised SIOP histologic classification of Wilms' tumors [9] .
Achievement of 1st CR occurred in 92.1% of cases and was significantly associated with stage. Almost 83% of cases that achieved 1st complete remission were stages I, II and III while 17% were stages IV and V with a highly significant statistical difference (P < 0.001). This highlights the strength of stage as a prognostic factor in Wilms' tumor.
Relapse-free-survival (RFS) at 3 years in our study (65%) was lower than what was reported by the 9th SIOP [22] study which showed a 5-year RFS of 82%. This could be explained by the advanced stage at presentation in our patients and dominance of blastema morphology. On the other hand, our 3-year RFS was higher than what was reported by Abd El-Aal et al. [23] who found that the 4-year RFS was 58%. This may be attributed to the improved treatment results in our cases. Stage affected 3-year RFS significantly as it was more in stages I, II and III than in stages IV and V (75.4% versus 50%). These results coincide with those reported by Hill et al. [6] and Abd ElAal et al. [23] who concluded that stage significantly affected survival. This again highlights the role of stage in predicting the prognosis of patients with Wilms' tumor. In our study, there was a tendency for lower 3-year RFS in cases with blastema dominant morphology than others, but unfortunately the difference could not attain statistical significance (p = 0.081). This could be attributed to the small number of patients, especially that p-value is close to the significant level.
Overall survival (OS) at 3 years in our study was 68.5%, which was lower than other Western studies. In the 2nd UKCCS and the 9th SIOP study, the 5-year OS were 83% and 87%, respectively. This reflects their better local and metastatic control with proper supportive care, beside dominance of advanced stage in our cases augmented by poor performance and nutritional status.
Advanced stage (IV and V) significantly lowered the 3-year OS into 40% of our patients in contrast to 77.8% for stages I, II and III (p = 0.002). This is in agreement with Abd El-Aal et al. [23] who reported that stage significantly affected survival and this reinforces the role of stage as a potent prognostic factor with special emphasis on patients with abdominal disease as they still have a better chance than others who have distant metastatic disease.
Our study demonstrated the 3-year OS for cases with blastema dominant morphology to be 54.8% compared to 80.9% for cases with non blastema dominant morphology with significant difference (p = 0.042). Our figure for patients with non blastema dominant morphology is comparable to that reported by the SIOP 93-01 (90%) [18] while that obtained with blastema dominant morphology is lower (79%). This again emphasizes their better supportive care especially during intensified chemotherapeutic regimens.
It was noticed that 3-year RFS and 3-year OS in females were shorter than in males with significant statistical difference. This could be explained by the prevalence of advanced stage (IV and V) in females rather than the gender itself as by multivariate analysis using the Cox proportional hazards model for effect of prognostic factors on relapse free survival and overall survival, stage was the only independent significant prognostic factor. The chance of relapse among stages IV and V was 3 times more than others (p = 0.016, 95% CI for HR 1.23-7.58). The probability of death among stages IV and V was 3.8 times more than others (p = 0.004, 95% CI for HR 1.55-9.45).
Conclusion
The morphologic response to preoperative chemotherapy is considered as an in vivo test for effectiveness of these drugs which is very important in planning the postoperative treatment plan.
Tumor stage and morphologic subtypes were found to be the most important determinants of prognosis of Wilms' tumor in our study and they deserve priority in precise and meticulous sampling of the nephrectomy specimen for proper assessment of stage and assessment of chemotherapy induced changes for better categorization of the patients regarding post operative treatment. This also helps in defining anaplasia and various grades of nuclear unrest in larger number of patients for further studies to clarify exactly the weight of nuclear unrest in Wilms' tumor.
Nuclear unrest represents an intermediary in the spectrum from favorable histology to anaplastic histology and nuclear unrest grade III is a very close station to anaplastic morphology especially if associated with p53 overexpression. p53 is linked to blastema dominant morphology, nuclear unrest grade III and anaplastic histology. Blastema dominant morphology is associated with poor survival. More studies are needed to confirm grouping of grade III nuclear unrest with anaplastic histology for treatment purposes as it may be appropriate to design a future study for treatment of Wilms' tumor with special consideration to patients having blastema dominant morphology, nuclear unrest grade III and p53 overexpression in a similar way to patients having tumors with anaplastic histology.
